Meiji Yasuda Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Meiji Yasuda Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,100	Closed	-$199K	–	450
2020 Q2	$199K	Buy	+16,100	New	+$182K	0.02%	458
2020 Q1	–	Sell	-13,500	Closed	-$132K	–	447
2019 Q4	$132K	Hold	13,500	–	–	0.01%	495
2019 Q3	$93K	Hold	13,500	–	–	0.01%	483
2019 Q2	$125K	Sell	13,500 -800	-6%	-$9.65K	0.01%	496
2019 Q1	$224K	Hold	14,300	–	–	0.02%	455
2018 Q4	$221K	Buy	14,300 +100	+0.7%	+$2.05K	0.02%	438
2018 Q3	$306K	Buy	14,200 +1,000	+8%	+$23.2K	0.02%	431
2018 Q2	$321K	Sell	13,200 -800	-6%	-$16.3K	0.03%	423
2018 Q1	$239K	Buy	14,000 +2,200	+19%	+$43K	0.02%	459
2017 Q4	$224K	Sell	11,800 -5,400	-31%	-$81.2K	0.02%	468
2017 Q3	$303K	Hold	17,200	–	–	0.03%	433
2017 Q2	$571K	Sell	17,200 -900	-5%	-$27.9K	0.06%	328
2017 Q1	$581K	Hold	18,100	–	–	0.06%	313
2016 Q4	$656K	Buy	+18,100	New	+$723K	0.07%	281

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Meiji Yasuda Asset Management's TEVA Position: Q3 2020 in Review

Meiji Yasuda Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2020, closing a stake of 16,100 shares — an estimated $199K sold.

Meiji Yasuda Asset Management first reported a position in TEVA in Q4 2016 and held it in 14 quarters. The position peaked at $656K in Q4 2016. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Meiji Yasuda Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2020 after selling out during the quarter.
Meiji Yasuda Asset Management sold 16,100 Teva Pharmaceutical Industries Limited shares in Q3 2020, an estimated $199K.
Meiji Yasuda Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 14 quarters.
Meiji Yasuda Asset Management's Teva Pharmaceutical Industries Limited position peaked at $656K in Q4 2016.
444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Meiji Yasuda Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.